NanoViricides Inc (NNVC)

[arvitar]

It is a simple fact that in all of human history, there has never been a single instance of a management team first failing to get a single preclinical candidate IND-approved after 11 years and $65M, and then suddenly accomplishing that with 20 months left until bankruptcy.

There's no reason to believe that NNVC will be the first.

Indeed, given the age and unremarkable careers of its management team, there's plenty of reason to believe that NNVC won't be the first to set such historic precedent.